The immune landscape of undifferentiated pleomorphic sarcoma.
Saved in:
| Title: | The immune landscape of undifferentiated pleomorphic sarcoma. |
|---|---|
| Authors: | Lazcano R; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Barreto CM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Salazar R; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Carapeto F; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Traweek RS; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Leung CH; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Gite S; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mehta J; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ingram DR; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wani KM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Vu KT; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Parra ER; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lu W; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Zhou J; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Witt RG; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Cope B; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Thirasastr P; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lin HY; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Scally CP; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Conley AP; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ratan R; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Livingston JA; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Zarzour AM; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ludwig J; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Araujo D; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ravi V; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Patel S; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Benjamin R; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wargo J; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wistuba II; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Somaiah N; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Roland CL; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Keung EZ; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Solis L; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang WL; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Lazar AJ; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nassif EF; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Oct 12; Vol. 12, pp. 1008484. Date of Electronic Publication: 2022 Oct 12 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36313661 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The immune landscape of undifferentiated pleomorphic sarcoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lazcano+R%22">Lazcano R</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Barreto+CM%22">Barreto CM</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Salazar+R%22">Salazar R</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Carapeto+F%22">Carapeto F</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Traweek+RS%22">Traweek RS</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Leung+CH%22">Leung CH</searchLink>; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Gite+S%22">Gite S</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Mehta+J%22">Mehta J</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ingram+DR%22">Ingram DR</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wani+KM%22">Wani KM</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Vu+KT%22">Vu KT</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Parra+ER%22">Parra ER</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Lu+W%22">Lu W</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Witt+RG%22">Witt RG</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Cope+B%22">Cope B</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Thirasastr+P%22">Thirasastr P</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Lin+HY%22">Lin HY</searchLink>; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Scally+CP%22">Scally CP</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ratan+R%22">Ratan R</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Livingston+JA%22">Livingston JA</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Zarzour+AM%22">Zarzour AM</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ludwig+J%22">Ludwig J</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Araujo+D%22">Araujo D</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ravi+V%22">Ravi V</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Patel+S%22">Patel S</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Benjamin+R%22">Benjamin R</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wargo+J%22">Wargo J</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wistuba+II%22">Wistuba II</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Somaiah+N%22">Somaiah N</searchLink>; Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Roland+CL%22">Roland CL</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Keung+EZ%22">Keung EZ</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Solis+L%22">Solis L</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wang+WL%22">Wang WL</searchLink>; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Division of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States.; Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Nassif+EF%22">Nassif EF</searchLink>; Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Oct 12; Vol. 12, pp. 1008484. <i>Date of Electronic Publication: </i>2022 Oct 12 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36313661 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2022.1008484 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1008484 Titles: – TitleFull: The immune landscape of undifferentiated pleomorphic sarcoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lazcano R – PersonEntity: Name: NameFull: Barreto CM – PersonEntity: Name: NameFull: Salazar R – PersonEntity: Name: NameFull: Carapeto F – PersonEntity: Name: NameFull: Traweek RS – PersonEntity: Name: NameFull: Leung CH – PersonEntity: Name: NameFull: Gite S – PersonEntity: Name: NameFull: Mehta J – PersonEntity: Name: NameFull: Ingram DR – PersonEntity: Name: NameFull: Wani KM – PersonEntity: Name: NameFull: Vu KT – PersonEntity: Name: NameFull: Parra ER – PersonEntity: Name: NameFull: Lu W – PersonEntity: Name: NameFull: Zhou J – PersonEntity: Name: NameFull: Witt RG – PersonEntity: Name: NameFull: Cope B – PersonEntity: Name: NameFull: Thirasastr P – PersonEntity: Name: NameFull: Lin HY – PersonEntity: Name: NameFull: Scally CP – PersonEntity: Name: NameFull: Conley AP – PersonEntity: Name: NameFull: Ratan R – PersonEntity: Name: NameFull: Livingston JA – PersonEntity: Name: NameFull: Zarzour AM – PersonEntity: Name: NameFull: Ludwig J – PersonEntity: Name: NameFull: Araujo D – PersonEntity: Name: NameFull: Ravi V – PersonEntity: Name: NameFull: Patel S – PersonEntity: Name: NameFull: Benjamin R – PersonEntity: Name: NameFull: Wargo J – PersonEntity: Name: NameFull: Wistuba II – PersonEntity: Name: NameFull: Somaiah N – PersonEntity: Name: NameFull: Roland CL – PersonEntity: Name: NameFull: Keung EZ – PersonEntity: Name: NameFull: Solis L – PersonEntity: Name: NameFull: Wang WL – PersonEntity: Name: NameFull: Lazar AJ – PersonEntity: Name: NameFull: Nassif EF IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 10 Text: 2022 Oct 12 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |